EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitVergleichsstudieOpen Access · CC BY 4.0

Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review

Wolfgang Kämmerer

Human Psychopharmacology: Clinical and Experimental · 2024

DOI: 10.1002/hup.2910 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2024. Verfasst von Wolfgang Kämmerer. Beteiligte Einrichtung: Medical Faculty, University of Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Central Nervous System Stimulants, Dextroamphetamine, Lisdexamfetamine Dimesylate. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine (LDX).

Methods

A search of Medline and Embase was conducted to identify relevant articles for this literature review.

Results

Dexamphetamine and LDX, a prodrug of dexamphetamine, are indicated for the treatment of attention‐deficit/hyperactivity disorder. It has been suggested that LDX may have a reduced potential for oral abuse compared to immediate‐release dexamphetamine. As a prodrug, LDX has the same pharmacodynamic properties as dexamphetamine. A study in healthy adults showed that the pharmacokinetic profile of dexamphetamine following oral administration of LDX is essentially identical to that of an equimolar dose of dexamphetamine administered 1 h later. In addition, dexamphetamine produced subjective drug liking effects comparable to those produced by LDX. LDX showed linear dose proportional pharmacokinetics up to a dose of 250 mg, indicating a lack of overdose protection at supratherapeutic doses. Furthermore, the exposure to dexamphetamine released from LDX may be prolonged by the consumption of alkalizing agents.

Conclusions

The available evidence from pharmacodynamic, pharmacokinetic and abuse liability studies suggests a comparable potential for oral abuse of dexamphetamine and LDX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System StimulantsDextroamphetamineLisdexamfetamine DimesylateAnimalsHumansAdministration, OralAttention Deficit Disorder with HyperactivityDose-Response Relationship, DrugProdrugsSubstance-Related Disorders

Stichwörter der Autor:innen

abusedexamphetaminelisdexamfetaminepharmacokineticspharmacology

Substanzen

Central Nervous System StimulantsDextroamphetamineLisdexamfetamine DimesylateProdrugs

Autor:innen und Institutionen

  • Medical Faculty, University of Augsburg, Augsburg, Germany.

Zitieren

APA

Kämmerer, W. (2024). Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2910

Vancouver

Kämmerer W. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review. Human Psychopharmacology: Clinical and Experimental. 2024. doi:10.1002/hup.2910

BibTeX
@article{Kmmerer2024,
  author = {Kämmerer, Wolfgang},
  title = {Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2024},
  doi = {10.1002/hup.2910}
}
Kostenlos starten →